BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19878774)

  • 1. Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.
    Wyatt A; Yerbury J; Poon S; Dabbs R; Wilson M
    Adv Cancer Res; 2009; 104():89-114. PubMed ID: 19878774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity.
    Wilson MR; Yerbury JJ; Poon S
    Mol Biosyst; 2008 Jan; 4(1):42-52. PubMed ID: 18075673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function?
    Carver JA; Rekas A; Thorn DC; Wilson MR
    IUBMB Life; 2003 Dec; 55(12):661-8. PubMed ID: 14769002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin.
    Yerbury JJ; Rybchyn MS; Easterbrook-Smith SB; Henriques C; Wilson MR
    Biochemistry; 2005 Aug; 44(32):10914-25. PubMed ID: 16086594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glycosylation on the structure and function of the extracellular chaperone clusterin.
    Stewart EM; Aquilina JA; Easterbrook-Smith SB; Murphy-Durland D; Jacobsen C; Moestrup S; Wilson MR
    Biochemistry; 2007 Feb; 46(5):1412-22. PubMed ID: 17260971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein J (clusterin) and Alzheimer's disease.
    Calero M; Rostagno A; Matsubara E; Zlokovic B; Frangione B; Ghiso J
    Microsc Res Tech; 2000 Aug; 50(4):305-15. PubMed ID: 10936885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins.
    Meredith SC
    Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular chaperones.
    Dabbs RA; Wyatt AR; Yerbury JJ; Ecroyd H; Wilson MR
    Top Curr Chem; 2013; 328():241-68. PubMed ID: 22076079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.
    Trougakos IP; Gonos ES
    Adv Cancer Res; 2009; 104():171-210. PubMed ID: 19878777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of extracellular chaperones in amyloidosis.
    Wyatt AR; Yerbury JJ; Dabbs RA; Wilson MR
    J Mol Biol; 2012 Aug; 421(4-5):499-516. PubMed ID: 22248589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins.
    Naiki H; Nagai Y
    J Biochem; 2009 Dec; 146(6):751-6. PubMed ID: 19643812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity.
    French K; Yerbury JJ; Wilson MR
    Biochemistry; 2008 Jan; 47(4):1176-85. PubMed ID: 18171086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.
    Cole GM; Ard MD
    Microsc Res Tech; 2000 Aug; 50(4):316-24. PubMed ID: 10936886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin in neurological disorders: molecular perspectives and clinical relevance.
    Charnay Y; Imhof A; Vallet PG; Kovari E; Bouras C; Giannakopoulos P
    Brain Res Bull; 2012 Aug; 88(5):434-43. PubMed ID: 22617144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between multifunctional protein "clusterin" and Alzheimer disease.
    Choi-Miura NH; Oda T
    Neurobiol Aging; 1996; 17(5):717-22. PubMed ID: 8892344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.